Maximus (NYSE:MMS) Releases Earnings Results, Beats Expectations By $0.26 EPS

Maximus (NYSE:MMS) issued its earnings results on Wednesday. The health services provider reported $1.57 EPS for the quarter, topping analysts’ consensus estimates of $1.31 by $0.26, Briefing.com reports. The firm had revenue of $1.35 billion during the quarter, compared to the consensus estimate of $1.29 billion. Maximus had a net margin of 3.73% and a return on equity of 15.68%. The company’s revenue was up 11.7% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $0.80 earnings per share. Maximus updated its FY24 guidance to $5.65-5.85 EPS and its FY 2024 guidance to 5.650-5.850 EPS.

Maximus Stock Performance

MMS traded down $0.08 during trading on Thursday, hitting $84.04. 453,130 shares of the stock were exchanged, compared to its average volume of 326,124. The firm has a market capitalization of $5.13 billion, a P/E ratio of 28.75 and a beta of 0.72. Maximus has a 1-year low of $72.39 and a 1-year high of $90.65. The stock has a fifty day moving average price of $82.34 and a two-hundred day moving average price of $81.63. The company has a quick ratio of 1.69, a current ratio of 1.69 and a debt-to-equity ratio of 0.71.

Maximus Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Friday, May 31st. Shareholders of record on Wednesday, May 15th will be given a dividend of $0.30 per share. This represents a $1.20 annualized dividend and a yield of 1.43%. The ex-dividend date is Tuesday, May 14th. Maximus’s dividend payout ratio (DPR) is 39.74%.

Insiders Place Their Bets

In other Maximus news, CFO David Mutryn sold 8,000 shares of Maximus stock in a transaction that occurred on Friday, February 16th. The stock was sold at an average price of $83.95, for a total transaction of $671,600.00. Following the transaction, the chief financial officer now owns 5,124 shares of the company’s stock, valued at $430,159.80. The transaction was disclosed in a filing with the SEC, which is available at this link. 1.40% of the stock is currently owned by corporate insiders.

Wall Street Analyst Weigh In

Separately, StockNews.com upgraded shares of Maximus from a “hold” rating to a “buy” rating in a research note on Thursday, February 8th.

About Maximus

Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.